https://akassogloulab.org/wp-content/uploads/2019/11/MedaRed.jpg 628 715 Marisa de la Cruz /wp-content/uploads/2017/01/katerina-akassoglou-lab-all-caps-gladstone-ucsf-501x133-new.png Marisa de la Cruz2019-10-08 23:01:312023-05-22 22:56:25New Bay Area Spin-Off Company to Develop Drugs for Multiple Sclerosis and Alzheimer’s Disease
New Bay Area Spin-Off Company to Develop Drugs for Multiple Sclerosis and Alzheimer’s Disease
October 8, 2019
Click here to read full article.
Gladstone team of (from left) Jae Kyu Ryu, Anke Meyer-Franke, Katerina Akassoglou, and Stephen Freedman worked with entrepreneur Edward Spack to launch MedaRed, Inc.